Nikica Sabljic

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Impact of Leukapheresis and Biological Risk Markers on Early Mortality in Patients with Hyperleukocytic Acute Myeloid Leukemia.

Impact of Leukapheresis and Biological Risk Markers on Early Mortality in Patients with Hyperleukocytic Acute Myeloid Leukemia.

Journal: Medicina (Kaunas, Lithuania)

Published: November 19, 2025

The Comparison of Classical Statistical and Machine Learning Methods in Prediction of Thrombosis in Patients with Acute Myeloid Leukemia.

The Comparison of Classical Statistical and Machine Learning Methods in Prediction of Thrombosis in Patients with Acute Myeloid Leukemia.

Journal: Bioengineering (Basel, Switzerland)

Published: December 01, 2024

Risk Factors for Venous Thromboembolism in Acute Promyelocytic Leukemia.

Risk Factors for Venous Thromboembolism in Acute Promyelocytic Leukemia.

Journal: Cancers

Published: November 04, 2024

Antibiotic resistance patterns of multidrug resistant bacteria in acute myeloid leukemia patients during induction treatment.

Antibiotic resistance patterns of multidrug resistant bacteria in acute myeloid leukemia patients during induction treatment.

Journal: Journal of infection in developing countries

Published: August 22, 2024

Deep venous thrombosis in patients with atresia of the inferior vena cava and right kidney hypoplasia (KILT syndrome): Systematic review of the literature.

Deep venous thrombosis in patients with atresia of the inferior vena cava and right kidney hypoplasia (KILT syndrome): Systematic review of the literature.

Journal: Vascular medicine (London, England)

Published: April 04, 2024

Thrombosis in Acute Promyelocytic Leukemia: The Current Understanding.

Thrombosis in Acute Promyelocytic Leukemia: The Current Understanding.

Journal: Hamostaseologie

Published: March 11, 2024

Can pharmacogenetics impact the therapeutic effect of cytarabine and anthracyclines in adult acute myeloid leukaemia patients?: A Serbian experience.

Can pharmacogenetics impact the therapeutic effect of cytarabine and anthracyclines in adult acute myeloid leukaemia patients?: A Serbian experience.

Journal: Journal of medical biochemistry

Published: December 15, 2023

Hemorrhage in acute promyelocytic leukemia-fibrinolysis in focus.

Hemorrhage in acute promyelocytic leukemia-fibrinolysis in focus.

Journal: Research and practice in thrombosis and haemostasis

Published: November 16, 2023

Incidence, risk factors, and outcome of asymptomatic central nervous system involvement in adult patients with acute myeloid leukemia.

Incidence, risk factors, and outcome of asymptomatic central nervous system involvement in adult patients with acute myeloid leukemia.

Journal: Hematological oncology

Published: August 29, 2023

The Role of the Spleen and the Place of Splenectomy in Autoimmune Hemolytic Anemia-A Review of Current Knowledge.

The Role of the Spleen and the Place of Splenectomy in Autoimmune Hemolytic Anemia-A Review of Current Knowledge.

Journal: Diagnostics (Basel, Switzerland)

Published: July 31, 2023

Venous thromboembolism in patients with acute myeloid leukemia: development of a predictive model.

Venous thromboembolism in patients with acute myeloid leukemia: development of a predictive model.

Journal: Thrombosis journal

Published: July 27, 2023

Arterial Thrombosis in Patients with Acute Myeloid Leukemia: Incidence and Risk Factors.

Arterial Thrombosis in Patients with Acute Myeloid Leukemia: Incidence and Risk Factors.

Journal: Cancers

Published: May 14, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026